Safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) as non-toxic therapy against myeloid and lymphoid cancers

Mise à jour : Il y a 4 ans
Référence : ISRCTN99131400

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

http://cancerhelp.cancerresearchuk.org/trials/trial-looking-new-combination-drugs-some-types-leukaemia-lymphoma


Critère d'inclusion

  • Acute Myeloblastic Leukaemia or high risk myelodysplasia (RAEB2 WHO criteria) (AML), B cell Chronic Lymphocytic Leukaemia (CLL) and B cell Non Hodgkins Lymphoma (BNHL)

Liens